Manraj Singh Sra (@manrajsra) 's Twitter Profile
Manraj Singh Sra

@manrajsra

Research Fellow in Hematology @MayoClinic, MBBS @AIIMS_NewDelhi. Views mine.

ID: 1241045318428266497

calendar_today20-03-2020 16:54:04

74 Tweet

416 Followers

1,1K Following

Manraj Singh Sra (@manrajsra) 's Twitter Profile Photo

It was great to discuss FAQs regarding ICMR STS and my project. Hope it's useful for med students planning to start research. Shout out to Dr. Amulya Gupta for this amazing initiative 🙌

Peter Gao (@planetarygao) 's Twitter Profile Photo

Something to consider as you read about the big Venus news today: there is an unfortunate disconnect between what we do as scientists and how "science" is communicated to everyone. A thread.

The Wire (@thewire_in) 's Twitter Profile Photo

India provides a unique habitat in which practitioners of alternative medicinal traditions can survive. A general lack of awareness, together with desperation brought on by the pandemic, prompt people to fall prey to false remedies. | Dr. Amulya Gupta science.thewire.in/health/covid-1…

Kai Kupferschmidt (@kakape) 's Twitter Profile Photo

I suspect we can all use a tiny break from refreshing our browsers and since we’re thinking a lot about vaccines and vaccine delivery these days, let me share sth with you that I learnt recently about the world’s first vaccine, the smallpox vaccine and that kind of blew my mind.

iCART | COVID-19 analytics for India (@icart_india) 's Twitter Profile Photo

The COVID-19 Meta-Resource help.covidtoday.in What: a search engine/yellow pages for resource portals, apps, bots: including govt, crowdsourced & volunteer orgs; sorted by location and reliability. Why: removes the need to find the forwarded messages you rcv How: clip 👇🏼

Manraj Singh Sra (@manrajsra) 's Twitter Profile Photo

Our analysis of the retracted COVID-19 papers shows that pre-prints are retracted significantly faster than peer-reviewed articles. Retraction Watch medrxiv.org/content/10.110…

Our analysis of the retracted COVID-19 papers shows that pre-prints are retracted significantly faster than peer-reviewed articles. <a href="/RetractionWatch/">Retraction Watch</a> medrxiv.org/content/10.110…
Gurwinder (@g_s_bhogal) 's Twitter Profile Photo

When intelligent people succumb to ideology, their intellect ceases to guard against wishful thinking and instead begins to fortify it, causing them to inadvertently mastermind their own delusion, and to very cleverly become stupid. My new essay. gurwinder.substack.com/p/why-smart-pe…

Manraj Singh Sra (@manrajsra) 's Twitter Profile Photo

Addition of olanzapine as a 4th line anti-emetic is cost-effective for children and adolescents receiving HEC in 🇮🇳🇧🇩🇮🇩🇬🇧🇺🇸 Read our latest paper in BMJ SPCare spcare.bmj.com/content/early/… Shuvadeep Ganguly Ramavath Dev Sameer Bakhshi

Manraj Singh Sra (@manrajsra) 's Twitter Profile Photo

Are abemaciclib and ribociclib cost-effective for early breast cancer in India? Our study finds they are not. Prices must drop by at least 78.61% for abemaciclib and 87.19% for ribociclib to be cost-effective. Shuvadeep Ganguly JCO Global Oncology bit.ly/3Wdo4RY

JCO Global Oncology (@jcogo_asco) 's Twitter Profile Photo

Cost-Effectiveness of Adjuvant Abemaciclib and Ribociclib in High-Risk Hormone Receptor-Positive Early Breast Cancer: An Indian Perspective ➡️ brnw.ch/21wLvGk #bcsm

Manraj Singh Sra (@manrajsra) 's Twitter Profile Photo

Our analysis shows that efanesoctocog alfa, currently priced at $900k/year, would need a 47% price cut to be cost-effective in the US.